Form 4 for IDXX Idexx Laboratories
Accepted 2023-09-06 00:00:00 ET · period of report 2023-09-01 · accession 0000874716-23-000121 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-06 | 2023-09-01 | IDXX | Smith Martin Alexander | EVP | M - OptEx | $0.00 | +19 | 225.70 | +9% | $0 |
| D | 2023-09-06 | 2023-09-01 | IDXX | Smith Martin Alexander | EVP | F - Tax | $511.29 | -5 | 220.70 | -2% | -$2,556 |
| D | 2023-09-06 | 2023-09-01 | IDXX | Smith Martin Alexander | EVP | M - OptEx | — | -19 | 1,827 | -1% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-09-01 | M | A | 19 | $0.00 | 225.70 | D | — | — | (F1) Includes a total of 26.7030 shares purchased under the Issuer's Employee Stock Purchase Plan on March 31, 2023 and June 30, 2023. |
| 2 | Common | Common Stock | 2023-09-01 | F | D | 5 | $511.29 | 220.70 | D | — | — | |
| 3 | Derivative | Restricted Stock Unit | 2023-09-01 | M | D | 19 | — | 1,827 | D | — · — to — | 19 Common Stock | (F3) Not applicable. (F2) Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning September 1, 2022. |